Where do Stoke Therapeutics, Inc.'s ratios come from?

Every ratio is computed from Stoke Therapeutics, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

	Q1 '26	Q4 '25	Q3 '25	Q2 '25	Q1 '25
Profitability
Operating margin	-577.5%-566pp	-11.2%-24.4pp	13.2%-6.9pp	20.2%+0.1pp	20%+297pp
Net margin	-529.2%-525pp	-3.7%-23.5pp	19.7%-6.5pp	26.3%-0.1pp	26.3%+270pp
EBITDA margin	-572.1%-562pp	-10.2%-24.4pp	14.1%-7.0pp	21.1%0.0pp	21.1%+292pp
Returns
Return on equity	-45.6%-43.2pp	-2.4%-17.4pp	15%-3.2pp	18.2%-2.3pp	20.5%+66.3pp
Return on assets	-39.9%-37.9pp	-2%-14.4pp	12.4%-2.7pp	15.2%-1.3pp	16.4%+52.0pp
Return on invested capital	-114.4%-104pp	-10.9%-28.2pp	17.3%-10.1pp	27.4%—	——
Efficiency
Asset turnover	0.1×-0.5×	0.5×-0.1×	0.6×+0.1×	0.6×0.0×	0.6×+0.5×
Liquidity
Current ratio	9×+3.7×	5.3×-1.2×	6.5×-0.5×	7×-1.4×	8.4×+2.6×
Quick ratio	9×+3.7×	5.3×-1.2×	6.5×-0.5×	7×-1.4×	8.4×+2.6×
Cash ratio	3.8×+2.4×	1.5×-0.5×	2×-0.6×	2.6×-3.5×	6.2×+3.0×
Leverage
Debt-to-equity	0×0.0×	0×0.0×	0×0.0×	0×0.0×	0×0.0×
Debt-to-assets	0×0.0×	0×0.0×	0×0.0×	0×0.0×	0×0.0×
Interest coverage	-13×-11.5×	-1.5×-3.6×	2.1×-1.0×	3.1×+0.1×	2.9×+10.9×
Per Share
Book value per share	$6.26+5.2%	$5.95+13.2%	$5.26-8.4%	$5.74-2.6%	$5.89+39.0%
Valuation
Market capitalization	$1.93B+6.2%	$1.81B+40.8%	$1.29B+105%	$628.41M+74.7%	$359.62M-38.4%
Enterprise value	$1.77B+2.4%	$1.73B+43.7%	$1.21B+127%	$532.22M+486%	$90.75M-80.3%
Price / sales	60×+50.2×	9.8×+3.6×	6.3×+3.1×	3.1×+1.3×	1.9×-14.1×
Price / book	4.9×-0.3×	5.1×+1.0×	4.2×+2.3×	1.9×+0.8×	1×-1.5×
EV / sales	55.3×+45.9×	9.4×+3.5×	5.9×+3.2×	2.7×+2.2×	0.5×-12.1×
Earnings yield	-8.8%-8.4pp	-0.4%-3.5pp	3.2%-5.2pp	8.4%-5.6pp	14%+29.2pp

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Where do Stoke Therapeutics, Inc.'s ratios come from?: Every ratio is computed from Stoke Therapeutics, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.